VVOS - Vivos Therapeutics Inc
2.73
0.160 5.861%
Share volume: 55,861
Last Updated: 05-07-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$2.57
0.16
0.06%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 06-08-2023 | 08-16-2023 | 11-14-2023 | 05-14-2024 | 08-14-2024 | 11-14-2024 | |
| Total revenue | 3.857 M | 3.395 M | 3.301 M | 3.419 M | 4.054 M | 3.860 M | |
| Cost of revenue | 1.520 M | 1.297 M | 1.403 M | 1.482 M | 1.403 M | 1.526 M | |
| Gross profit | 2.337 M | 2.098 M | 1.898 M | 1.937 M | 2.651 M | 2.334 M | |
| -10.23% | -9.53% | 2.05% | 36.86% | -11.96% | |||
| Operating expenses | 7.167 M | 6.467 M | 5.237 M | 4.921 M | 4.122 M | 4.487 M | |
| Selling general and admin | 7.167 M | 6.467 M | 5.237 M | 4.921 M | 4.122 M | 4.487 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 8.862 M | 7.912 M | 6.790 M | 5.722 M | 4.587 M | 4.979 M | |
| -10.72% | -14.18% | -15.73% | -19.84% | 8.55% | |||
| Operating income | -5.005 M | -4.517 M | -3.489 M | -3.785 M | -1.936 M | -2.645 M | |
| Ebit | -5.005 M | -4.517 M | -3.489 M | -3.763 M | -1.930 M | -2.616 M | |
| Pretax income | -1.703 M | -5.528 M | -2.093 M | -3.763 M | -1.930 M | -2.616 M | |
| 224.60% | -62.14% | 79.79% | -48.71% | 35.54% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -1.703 M | -5.528 M | -2.093 M | 0.000 | 0.000 | 0.000 | |
| -224.60% | 62.14% | 100.00% | |||||
| Net income | -1.703 M | -5.528 M | -2.093 M | -3.763 M | -1.930 M | -2.616 M | |
| -224.60% | 62.14% | -79.79% | 48.71% | -35.54% |
